Tag: cx2019
Highlights from the CX 2019 session, Paclitaxel: The last word
Watch the video roundup from the CX 2019 Highlight Session, Paclitaxel: The last word.
Filmed onsite at the Charing Cross Symposium (15–18 April 2019, London,...
CX 2019: Evidence supports safety of paclitaxel-coated devices
At the Charing Cross International Symposium, Gary Ansel (Columbus, Ohio) moderates a global panel that includes Thomas Albrecht (Berlin, Germany), Peter Schneider (San Francisco,...
CX 2019: Cook leads the way to data transparency with release...
There were calls for greater transparency and sharing of the available randomised controlled trial data of paclitaxel-coated devices at the CX 2019 Highlight Session, Paclitaxel:...
Positive outcomes of Eluvia drug-eluting stent in IMPERIAL sub-analyses
Boston Scientific has announced results from sub-analyses of the IMPERIAL clinical trial for the Eluvia Drug-Eluting Vascular Stent System at the 41st Charing Cross...
